These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 27469392)

  • 1. New insights into the stereochemical requirements of the bradykinin B1 receptor antagonists binding.
    Lupala CS; Gomez-Gutierrez P; Perez JJ
    J Mol Graph Model; 2016 Jul; 68():184-196. PubMed ID: 27469392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding.
    Lupala CS; Gomez-Gutierrez P; Perez JJ
    J Comput Aided Mol Des; 2016 Jan; 30(1):85-101. PubMed ID: 26697880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding modes of dihydroquinoxalinones in a homology model of bradykinin receptor 1.
    Ha SN; Hey PJ; Ransom RW; Harrell CM; Murphy KL; Chang R; Chen TB; Su DS; Markowitz MK; Bock MG; Freidinger RM; Hess FJ
    Biochem Biophys Res Commun; 2005 May; 331(1):159-66. PubMed ID: 15845373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding Mode Exploration of B1 Receptor Antagonists' by the Use of Molecular Dynamics and Docking Simulation-How Different Target Engagement Can Determine Different Biological Effects.
    Gemei M; Talarico C; Brandolini L; Manelfi C; Za L; Bovolenta S; Liberati C; Vecchio LD; Russo R; Cerchia C; Allegretti M; Beccari AR
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of the critical residues of bradykinin receptor B1 for interaction with the kinins guided by site-directed mutagenesis and molecular modeling.
    Ha SN; Hey PJ; Ransom RW; Bock MG; Su DS; Murphy KL; Chang R; Chen TB; Pettibone D; Hess JF
    Biochemistry; 2006 Dec; 45(48):14355-61. PubMed ID: 17128974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspartic acid scaffold in bradykinin B1 antagonists.
    Huszár J; Timár Z; Bogár F; Penke B; Kiss R; Szalai KK; Schmidt E; Papp A; Keseru G
    J Pept Sci; 2009 Jun; 15(6):423-34. PubMed ID: 19378355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ligand-supported homology modeling of the human angiotensin II type 1 (AT(1)) receptor: insights into the molecular determinants of telmisartan binding.
    Patny A; Desai PV; Avery MA
    Proteins; 2006 Dec; 65(4):824-42. PubMed ID: 17034041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of a potent, non-peptide bradykinin B1 receptor antagonist.
    Su DS; Markowitz MK; DiPardo RM; Murphy KL; Harrell CM; O'Malley SS; Ransom RW; Chang RS; Ha S; Hess FJ; Pettibone DJ; Mason GS; Boyce S; Freidinger RM; Bock MG
    J Am Chem Soc; 2003 Jun; 125(25):7516-7. PubMed ID: 12812482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bradykinin B₂ receptors increase hippocampal excitability and susceptibility to seizures in mice.
    Rodi D; Buzzi A; Barbieri M; Zucchini S; Verlengia G; Binaschi A; Regoli D; Boschi A; Ongali B; Couture R; Simonato M
    Neuroscience; 2013 Sep; 248():392-402. PubMed ID: 23811399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
    Axe FU; Bembenek SD; Szalma S
    J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular features characterizing non-peptide selectivity to the human B1 and B2 bradykinin receptors.
    Rasaeifar B; Lupala CS; Gomez-Gutierrez P; Perez JJ
    Bioorg Med Chem Lett; 2019 Jan; 29(1):11-14. PubMed ID: 30466897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro studies of a bradykinin B1/B2 antagonist linked to a human neutrophil elastase inhibitor; a heterodimer for the treatment of inflammatory disorders.
    Leimer AH; Kroona HB; Blodgett JK; Whalley ET; Ross SE; Burkard MR; Zuzack JS; Gernert DL; Dyckes DF
    Can J Physiol Pharmacol; 1997 Jun; 75(6):633-8. PubMed ID: 9276141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-affinity binding of peptide agonists to the human B1 bradykinin receptor depends on interaction between the peptide N-terminal L-lysine and the fourth extracellular domain of the receptor.
    Fathy DB; Kyle DJ; Leeb-Lundberg LM
    Mol Pharmacol; 2000 Jan; 57(1):171-9. PubMed ID: 10617692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization and radioligand binding properties of a high-affinity, nonpeptide, bradykinin B1 receptor antagonist.
    Ransom RW; Harrell CM; Reiss DR; Murphy KL; Chang RS; Hess JF; Miller PJ; O'Malley SS; Hey PJ; Kunapuli P; Su DS; Markowitz MK; Wallace MA; Raab CE; Jones AN; Dean DC; Pettibone DJ; Freidinger RM; Bock MG
    Eur J Pharmacol; 2004 Sep; 499(1-2):77-84. PubMed ID: 15363953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
    Jain V; Saravanan P; Arvind A; Mohan CG
    Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homology modeling of human CCR5 and analysis of its binding properties through molecular docking and molecular dynamics simulation.
    Shahlaei M; Madadkar-Sobhani A; Mahnam K; Fassihi A; Saghaie L; Mansourian M
    Biochim Biophys Acta; 2011 Mar; 1808(3):802-17. PubMed ID: 21167131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bradykinin receptor antagonists containing N-substituted amino acids: in vitro and in vivo B(2) and B(1) receptor antagonist activity.
    Goodfellow VS; Marathe MV; Kuhlman KG; Fitzpatrick TD; Cuadrado D; Hanson W; Zuzack JS; Ross SE; Wieczorek M; Burkard M; Whalley ET
    J Med Chem; 1996 Mar; 39(7):1472-84. PubMed ID: 8691478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular cloning and pharmacological characterization of the canine B1 and B2 bradykinin receptors.
    Hess JF; Hey PJ; Chen TB; O'Brien J; Omalley SS; Pettibone DJ; Chang RS
    Biol Chem; 2001 Jan; 382(1):123-9. PubMed ID: 11258662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Des-Arg9-bradykinin causes kinin B1 receptor mediated endothelium-independent contractions in endotoxin-treated porcine coronary arteries.
    More AS; Kim HM; Khang G; Hildebrandt T; Bernlöhr C; Doods H; Vanhoutte PM; Wu D
    Pharmacol Res; 2014 Dec; 90():18-24. PubMed ID: 25258294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.